<DOC>
	<DOCNO>NCT00936923</DOCNO>
	<brief_summary>A prospective , randomize , open-label , stratify , control clinical trial evaluate whether long term furosemide therapy ( 1 year ) would preserve urine volume and/or residual renal function ( RRF ) improve fluid state continuous ambulatory peritoneal dialysis ( CAPD ) patient .</brief_summary>
	<brief_title>Effect Diuretics Fluid Status Control Residual Renal Function Peritoneal Dialysis Patients</brief_title>
	<detailed_description>There 3 phase study . Phase 1 screen phase . Each subject evaluate determine he/she eligible study . Phase 2 intervention phage . Patients divide arbitrarily two group accord baseline RRF ( residual glomerular filtration rate [ rGFR ] &lt; 5or &gt; 5 ml/min ) , randomly receive 12 month treatment study drug ( furosemide 120mg daily , 60mg daily , diuretic ) . Phase 3 following-up phase , last 1 year . Dialytic prescription adjust independent study guide clinical parameter calculate clearance ( target creatinine clearance 65L/week , urea clearance Kt/V &gt; 1.7 per week ) . Blood pressure measure use automate blood pressure device , target level 135/85mmHg . The antihypertensive medication introduce body weigh reduce target level , ACEI /or ARB selection need cross-sectional design . The hydration state measure bioelectrical impedance analysis ( BIA ) .</detailed_description>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Furosemide</mesh_term>
	<mesh_term>Diuretics</mesh_term>
	<criteria>Willingness sign inform consent Age:20~70 year , regardless gender All patient receive CAPD 1 month ; Urine volume 500ml/d ; No history take furosemide least 2 week . Inability unwillingness sign inform consent Inability unwillingness meet scheme demand raise investigator Current acute infection peritonitis ; Severe diarrhea vomit within precede 1 month Acute Cardiac failure Myocardial infarction within precede 6 month ; Hypertensive encephalopathy cerebrovascular accident ; Accident within precede 6 month ; Any condition , alcohol drug abuse , chronic liver disease , malignant disease , psychiatric disorder ; Allergy intolerance furosemide . Current recent ( within 2 week ) exposure investigational drug</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>CAPD</keyword>
	<keyword>Diuretics</keyword>
	<keyword>Residual Renal Function</keyword>
	<keyword>furosemide</keyword>
</DOC>